The potential role of lung epithelial cells and β-defensins in experimental latent tuberculosis

Scandinavian Journal of Immunology

Volumn 67, Issue 5, 2008, Pages 448-452

  Rivas Santiago, B ^b   Contreras, J C L ^c   Sada, E ^d   Hernandez Pando R ^a,c  

^a National Institute of Medical Science and Nutrition   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; DISEASE MODEL; EPITHELIUM CELL; IMAGE ANALYSIS; IMMUNOELECTRON MICROSCOPY; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TUBERCULOSIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BETA-DEFENSINS; BRONCHI; EPITHELIAL CELLS; FEMALE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICROSCOPY, IMMUNOELECTRON; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 42049087904     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02088.x     Document Type: Article

References (29)

1. Yew WW, Leung CC. Update in tuberculosis 2005. Am J Respir Crit Care Med 2006 173 : 491 8.
2. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998 6 : 107 12.
3. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003 3 : 578 90.
4. Bermudez LE, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun 1996 64 : 1400 6.
5. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Adv Exp Med Biol 2003 531 : 241 7.
6. Durr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002 70 : 6515 7.
7. Ackermann MR, Gallup JM, Zabner J et al. Differential expression of sheep beta-defensin-1 and -2 and interleukin 8 during acute Mannheimia haemolytica pneumonia. Microb Pathog 2004 37 : 21 7.
8. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human beta-defensins. Cell Mol Life Sci 2006 11 : 1294 313.
9. Ganz T. Defensins: antimicrobial peptides of innate immunity. Immunology 2003 3 : 710 20.
10. Bals R. Epithelial peptides in host defense against infection. Respir Res 2000 1 : 141 50.
11. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 1991 88 : 3952 6.
12. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zassloff M. Human β-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis. Cell 1997 88 : 553 60.
13. Vora P, Youdim A, Thomas LS et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004 173 : 5398 405.
14. Hiemstra PS. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem Soc Trans 2006 34 : 276 8.
15. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human beta-defensins. Cell Mol Life Sci 2006 63 : 1294 313.
16. Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from toll-like receptors. Cell Microbiol 2007 5 : 1087 98.
17. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher AJ. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005 12 : 1715 24.
18. Rivas-Santiago B, Schwander SK, Sarabia C et al. Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 2005 73 : 4505 11.
19. Rivas-Santiago B, Sada E, Tsutsumi V, Aguilar-Leon D, Contreras JL, Hernandez-Pando R. Beta-defensin gene expression during the course of experimental tuberculosis infection. J Infect Dis 2006 194 : 697 701.
20. Nuermberger E, Bishai W, Grosset J. Latent tuberculosis infection. Semin Respir Crit Care Med 2004 25 : 317 36.
21. Hernandez-Pando R, Jeyanathan M, Mengistu G et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000 356 : 2133 8.
22. Arriaga AK, Orozco EH, Aguilar LD, Rook GA, Hernandez Pando R. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol 2002 128 : 229 37.
23. Rook GAW, Bloom BR. Mechanisms of pathogenesis in tuberculosis. In : Bloom BR, ed. Tuberculosis: Pathogenesis, Protection and Control. Washington : ASM Press, 1994 : 485 501.
24. Dannenberg AM. Immunopathogenesis of pulmonary tuberculosis. Hosp Pract 1993 28 : 51 8.
25. Lasco TM, Cassone L, Kamohara H, Yoshimura T, McMurray DN. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis (Edinb) 2005 85 : 245 58.
26. Iliopoulos A, Psathakis K, Aslanidis S, Skagias L, Sfikakis PP. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int J Tuberc Lung Dis 2006 10 : 588 590.
27. Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 1927 4 : 1 21.
28. Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW. Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis 1994 75 : 168 78.
29. Handler A, Lim J, Losick R. ΔahZ, CRAMP and cytokinesis. In : Cell Cycle and Cytoskeleton Elements in Bacteria. Copenhagen : EMBO. Abstracts Book, Carlsberg Academy, Aug 23-27, 2006 : 60.